On May 12, the U.S. Food and Drug Administration (FDA) approved VEOZAHTM (Fezolinetant), 45 mg once daily for the treatment of moderate…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
menopause
-
-
Pharma Science & Research
Phase III study shows safety of fezolinetant as non-hormonal treatment of VMS
by adminby adminSummary : The safety and efficacy of fezolinetant is being evaluated in the Phase III trial of over 1,800 women seeking relief…